We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biogen Idec Pays $20M To Settle Patent Suit With Corixa, GSK

Law360 (March 1, 2004, 12:00 AM EST) -- Biogen Idec agreed to pay $20 million to settle its outstanding patent litigation with rival Corixa and its marketing partner, GlaxoSmithKline, over patents for a cancer drug, the companies said Monday....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.